RxDoctor Payments Data

Charles Warren, DO

Family Medicine · Fleming Island, FLNPI 1154389112

Payments from drug & device makers

$3,293in general payments, 2019–2025

Across 209 payments — averaging $15.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$518
  • Novo Nordisk$445
  • AstraZeneca$307
  • Amgen$211
  • Astellas Pharma US Inc$177
  • Sanofi Pasteur Inc.$158
  • plus $1K from 26 others

What the payments were for

  • Food & beverage$3,19797%
  • Education$502%
  • Gifts$461%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,293 in reported general payments places this provider in the 80th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$38,627
Medicare patients
217
Services billed
722

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban33$40,396
OzempicSemaglutide29$40,142
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$22,450
JanuviaSitagliptin Phosphate17$20,375
FarxigaDapagliflozin Propanediol11$16,569
Breo ElliptaFluticasone/Vilanterol11$5,017
VascepaIcosapent Ethyl11$4,934
Fluticasone-SalmeterolFluticasone Propion/Salmeterol20$4,258
Atorvastatin Calcium388$4,213
Gabapentin122$2,401
Omeprazole146$2,214
Levothyroxine Sodium144$2,186
Celecoxib25$2,086
Rosuvastatin Calcium94$1,359
Aripiprazole15$1,334

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$120$40,39633 claims
Novo NordiskOzempic$445$40,14229 claims
GSKTrelegy Ellipta, Breo Ellipta$518$27,46834 claims
MerckJanuvia$152$20,37517 claims
AstraZenecaFarxiga$307$16,56911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Fleming Island

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →